A Novel AI-Based Method Reveals How Cells Respond to Drug Treatments

Researchers from Tel Aviv University have developed an innovative method that can help to understand better how cells behave in changing biological environments, such as those found within a cancerous tumor.

The new system, called scNET, combines information on gene expression at the single-cell level with information on gene interactions, enabling the identification of important biological patterns such as responses to drug treatments.

The scientific article published in the Nature Methods journal explains how scNET may improve medical research and assist in the development of treatments for diseases. The research was led by PhD student Ron Sheinin under the supervision of Prof. Asaf Madi, from the Faculty of Medicine, and Prof. Roded Sharan, head of the School of Computer Science and AI at Tel Aviv University.

Today, advanced sequencing technologies allow the measurement of gene expression at the single-cell level and, for the first time, researchers can investigate the gene expression profiles of different cell populations within a biological sample and discover their effects on the functional behavior of each cell type. One fascinating example is understanding the impact of cancer treatments – not only on the cancer cells themselves but also on the pro-cancer supporting cells or, alternatively, anti-cancer cell populations, such as some cells of the immune system surrounding the tumor.

Despite the amazing resolution, these measurements are characterized by high levels of noise, which makes it difficult to identify precise changes in genetic programs that underlie vital cellular functions. This is where scNET comes into play.

Ron Sheinin: "scNET integrates single-cell sequencing data with networks that describe possible gene interactions, much like a social network, providing a map of how different genes might influence and interact with each other. scNET enables more accurate identification of existing cell populations in the sample. Thus, it is possible to investigate the common behavior of genes under different conditions and to expose the complex mechanisms that characterize the healthy state or response to treatments."

Prof. Asaf Madi: "In this research, we focused on a population of T cells, immune cells known for their power to fight cancerous tumors. scNET revealed the effects of treatments on these T cells and how they became more active in their cytotoxic activity against the tumor, something that was not possible to discover before due to the high level of noise in the original data."

Prof. Roded Sharan: "This is an excellent example of how artificial intelligence tools can help decipher biological and medical data, allowing us to gain new and significant insights. The idea is to provide biomedical researchers with computational tools that will aid in understanding how the body's cells function, thereby identifying new ways to improve our health."

In conclusion, scNET demonstrates how the combination of AI with biomedical research could lead to the development of new therapeutic approaches, reveal hidden mechanisms in diseases, and propose new treatment options.

Sheinin R, Sharan R, Madi A.
scNET: learning context-specific gene and cell embeddings by integrating single-cell gene expression data with protein-protein interactions.
Nat Methods. 2025 Apr;22(4):708-716. doi: 10.1038/s41592-025-02627-0

Most Popular Now

Philips Foundation 2024 Annual Report: E…

Marking its tenth anniversary, Philips Foundation released its 2024 Annual Report, highlighting a year in which the Philips Foundation helped provide access to quality healthcare for 46.5 million people around...

New AI Transforms Radiology with Speed, …

A first-of-its-kind generative AI system, developed in-house at Northwestern Medicine, is revolutionizing radiology - boosting productivity, identifying life-threatening conditions in milliseconds and offering a breakthrough solution to the global radiologist...

Scientists Argue for More FDA Oversight …

An agile, transparent, and ethics-driven oversight system is needed for the U.S. Food and Drug Administration (FDA) to balance innovation with patient safety when it comes to artificial intelligence-driven medical...

New Research Finds Specific Learning Str…

If data used to train artificial intelligence models for medical applications, such as hospitals across the Greater Toronto Area, differs from the real-world data, it could lead to patient harm...

Giving Doctors an AI-Powered Head Start …

Detection of melanoma and a range of other skin diseases will be faster and more accurate with a new artificial intelligence (AI) powered tool that analyses multiple imaging types simultaneously...

AI Agents for Oncology

Clinical decision-making in oncology is challenging and requires the analysis of various data types - from medical imaging and genetic information to patient records and treatment guidelines. To effectively support...

Patients say "Yes..ish" to the…

As artificial intelligence (AI) continues to be integrated in healthcare, a new multinational study involving Aarhus University sheds light on how dental patients really feel about its growing role in...

Brains vs. Bytes: Study Compares Diagnos…

A University of Maine study compared how well artificial intelligence (AI) models and human clinicians handled complex or sensitive medical cases. The study published in the Journal of Health Organization...

'AI Scientist' Suggests Combin…

An 'AI scientist', working in collaboration with human scientists, has found that combinations of cheap and safe drugs - used to treat conditions such as high cholesterol and alcohol dependence...

Start-ups in the Spotlight at MEDICA 202…

17 - 20 November 2025, Düsseldorf, Germany. MEDICA, the leading international trade fair and platform for healthcare innovations, will once again confirm its position as the world's number one hotspot for...